Table 1 (abstract P4). Primary and secondary outcome comparing between hydrocortisone and placebo groups
From: Sepsis 2018
Outcome | Placebo (n=76) | Hydrocortisone (n=78) | Relative Risk (95%CI) | P |
|---|---|---|---|---|
Primary outcome: Survive with no organ support at 28 day (%) | 37 (48.7) | 48 (61.5) | 1.28 (0.93-1.76) | 0.12 |
Secondary outcome 28 day mortality (%) | 24 (31.6) | 19 (24.4) | 0.78 (0.59-1.18) | 0.32 |
Hospital mortality (%) | 35 (46.1) | 33 (42.3) | 0.93 (0.67-1.33) | 0.64 |
Ventilator dependent days | 14.6+9.3 | 12.0+8.0 | Â | 0.07 |
Days survive without ventilator in 28 days | 9.2+9.7 | 12.1+9.4 | Â | 0.07 |
Vasopressor dependent days | 6.8+5.7 | 4.8+3.0 | Â | 0.008 |
Days survive without vasopressor in 28 days | 17.1+9.4 | 19.3+8.5 | Â | 0.12 |
Renal replacement therapy (%) | 19 (25) | 21 (26.9) | 1.05 (0.70-1.57) | 0.79 |
RRT dependent days | 2.1+4.5 | 2.1+4.8 | Â | 1.0 |